Why Health Care Companies Are Eating Tech’s Lunch


In a year that saw a terrible Ebola pandemic in Africa and the resurgence of Legionnaire’s disease in New York, it’s small wonder that life sciences and health-care companies are also leading the way for initial public offerings. Still, it’s catching some off guard–particularly those who are bullish on the tech sector.

For 2015, a year in which volatility has returned to the stock market, with a correction in August that drove the Dow Jones Industrial Average down 13 percent, tech companies accounted for just 11 percent of initial public offerings. Meanwhile health-care stocks represented 44 percent of new IPOs. That’s according to new data from IPO researcher Renaissance Capital.


About Peter Coffaro 1439 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.